e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Doximity, Inc. Class A Common Stock (NY:DOCS)

43.43 -0.85 (-1.92%)

Streaming Delayed Price Updated: 1:39 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Doximity, Inc. Class A Common Stock

< Previous 1 2

...

19 20 21 22 23 24 25 26 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 09, 2022

Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 13.6% to $1.25 during Wednesday's pre-market session. The market value of their outstanding shares is at $13.1...

Via Benzinga

Why Doximity Shares Are Trading Higher Premarket Today? ↗

February 09, 2022

Doximity Inc (NYSE: DOCS) posted Q3 FY22 sales of $9

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 08, 2022

Gainers Sundial Growers (NASDAQ:SNDL) sto...

Via Benzinga

7 Best New Stocks on Robinhood Making Waves on the Platform ↗

February 03, 2022

Robinhood stocks took off during the pandemic as millennials spent stimulus funds on the market, and these picks can continue to thrive.

Via InvestorPlace

Why Jim Cramer Likes Illumina And Enterprise Products Partners ↗

January 06, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ:

Via Benzinga

Where Doximity Stands With Analysts ↗

December 02, 2021

Within the last quarter, Doximity (NYSE:DOCS) has observed the following anal...

Via Benzinga

Expert Ratings For Doximity ↗

November 10, 2021

Analysts have provided the following ratings for Doximity (NYSE:DOCS) within...

Via Benzinga

Earnings Scheduled For February 8, 2022 ↗

February 08, 2022

Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.

Via Benzinga

A New Year Won’t Fix Teladoc’s Long-Term Prognosis ↗

January 05, 2022

Teladoc is losing tons of money and TDOC stock isn't cheap on other metrics. As such, shares are a clear "avoid" for the time being.

Via InvestorPlace

EXCLUSIVE: Looking Back On The Best And Worst IPOs Of 2021 With IPO Warriors ↗

December 28, 2021

2021 was a record year for IPOs. More than 1,000 companies made public debuts, raising about $315 billion in the process. The previous record of about $200 billion...

Via Benzinga

31 Stocks Moving In Thursday's Mid-Day Session ↗

December 16, 2021

Gainers Calliditas Therapeutics AB (NASDAQ: CALT) shares climbed 28.7% to $24.13 after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce...

Via Benzinga

Jim Cramer Prefers NortonLifeLock Over McAfee ↗

December 15, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers NortonLifeLock Inc. (NASDAQ:

Via Benzinga

58 Biggest Movers From Yesterday ↗

December 17, 2021

Gainers Adagio Therapeutics, Inc. (NASDAQ: ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price...

Via Benzinga

Cramer Gives His Opinion On GlaxoSmithKline, Asana And More ↗

December 07, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Penn National Gaming, Inc. (NASDAQ:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021 ↗

December 14, 2021

Upgrades According to Wells Fargo, the prior rating for Douglas Emmett Inc (NYSE:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2021 ↗

December 02, 2021

Upgrades According to William Blair, the prior rating for Graco Inc (NYSE:

Via Benzinga

Jim Cramer Likes This Stock Over Cassava Sciences And Biogen ↗

November 17, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Cassava Sciences, Inc. (NASDAQ:

Via Benzinga

Stock Market Rally Cools On Hot Inflation; Rivian IPO Revs Higher, Elon Musk Sells Tesla Shares; GE, J&J Plan Breakups: Weekly Review ↗

November 12, 2021

The market rally paused its big run as inflation spiked. The Rivian IPO soared in its debut while Musk sold some Tesla shares.

Via Investor's Business Daily

Topics Initial Public Offering Stocks

Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021 ↗

November 17, 2021

Upgrades According to Williams Capital, the prior rating for On Holding AG (NYSE:

Via Benzinga

Doximity Stock Flashes Robust Vital Signs ↗

November 10, 2021

Doximity sees its Relative Strength Rating hit the elite 90-plus level.

Via Investor's Business Daily

Here's Why Doximity Stock Is Down Today ↗

November 10, 2021

Third-quarter earnings were positive, but the stock market is focused on the impending end of lock-up agreements.

Via The Motley Fool

Topics Initial Public Offering

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 10, 2021

Gainers Valneva (NASDAQ:VALN) shares increased by 24.51% to $50.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 10, 2021

Good morning, trader! It's time to start another busy day of trading with a dive into the biggest pre-market stock movers for Wednesday.

Via InvestorPlace

This Healthcare Stock Has a Huge Reach and Massive Revenue Growth Potential ↗

November 08, 2021

Amazing market penetration and untapped revenue potential make a nice combination.

Via The Motley Fool

These 2 Telehealth Companies Should Unite ↗

October 30, 2021

Here's why Doximity and OptimizeRx might want to consider a merger.

Via The Motley Fool

3 Leading Telehealth Stocks to Buy in 2021 and Beyond ↗

October 14, 2021

All three of these telehealth companies are already profitable and have solid financials.

Via The Motley Fool

Cramer Recommends To Hold Doximity, Avoid This Industry And Buy This Stock ↗

October 13, 2021

On CNBC’s “Mad Money...

Via Benzinga

1 Top Telehealth Stock to Buy for the Long Haul ↗

October 13, 2021

GoodRx is transforming the way people pay for prescriptions, and it is using telehealth to do it.

Via The Motley Fool

3 COVID Stocks That Can Turn $1,000 Into $10,000 ↗

October 12, 2021

Our trio of contributors offer three COVID-19 stocks that will zoom higher, even as we emerge from the pandemic.

Via The Motley Fool

This Is Healthcare Platform Doximity's Biggest Advantage ↗

October 05, 2021

It's hard to beat a strong network effect.

Via The Motley Fool

Topics Cannabis

< Previous 1 2

...

19 20 21 22 23 24 25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy